John Schieszer

This study investigated the effects of patients’ perceptions of their disease status and prognosis on quality of life and psychological distress.

Researchers conducted a secondary analysis of data from the phase 3 LY.12 clinical trial to measure effect of frailty on outcomes for patients with lymphoma.

A retrospective review of data from patients with CLL demonstrated varied adherence to guidelines for ramp up initiation and laboratory monitoring.

A retrospective review demonstrated that higher Adult Comorbidity Evaluation 27 scores are prognostic for poorer outcomes in patients with CML.

A retrospective review of women treated for breast cancer diagnosed in 2010-2016 demonstrated the effects of delays in time to surgery for DCIS and cT1-2N0 disease.

Survey results show that parents are in agreement with their adolescents with cancer regarding some concerns but not all.

The association between functional impairment and symptom burden was shown to be predictive of outcomes for older patients with advanced cancer.

Researchers feed a series of scenarios involving poor or negative outcomes into various hospitals’ EHR systems to measure their safety in detecting dangerous medication errors.

Histology-tailored neoadjuvant chemotherapy failed to show superiority compared with standard neoadjuvant chemotherapy in patients with high-risk STS.

Clinicians may be underappreciating the extent of adverse events in women with cervical and endometrial cancer who undergo radiotherapy.